MITCHELL GOLDSTEIN: Open Payments
NPI 1659335636 · SOUTH BEND, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,640 in 87 payments from 13 companies in 2025. Trend: 2023 $748 · 2024 $1,194 · 2025 $1,640
Food & beverage: $1,640
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 17 | $526 |
| Alkermes, Inc. | 27 | $355 |
| Lundbeck LLC | 10 | $168 |
| Corium, LLC | 10 | $134 |
| Otsuka America Pharmaceutical, Inc. | 4 | $88 |
| Neurocrine BioSciences, Inc. | 4 | $74 |
| ABBVIE INC. | 4 | $71 |
| Axsome Therapeutics, Inc. | 2 | $48 |
| Vanda Pharmaceuticals Inc. | 2 | $45 |
| Teva Pharmaceuticals USA, Inc. | 2 | $36 |
Products named: COBENFY, ARISTADA, ABILIFY MAINTENA, Azstarys, ABILIFY ASIMTUFII, INGREZZA, VRAYLAR, Auvelity.
Industry payments across IN — which companies pay providers there.
